Study details
Enrolling now
Wellness Intervention for Smoking and HIV
University of Arizona
NCT IDNCT04725617ClinicalTrials.gov data as of Apr 2026
Target enrollment
200
Study length
about 3.9 years
Ages
18–75
Locations
2 sites in AZ
About this study
This trial is testing a personalized approach to reduce smoking versus another health intervention on smoking cessation, healthy sleep metrics, and cardiovascular risk biomarkers in adults with HIV who smoke. Participants will receive varenicline and counseling sessions while being monitored for side effects.
Based on ClinicalTrials.gov records.
What participants do
- 1.Health Approach 2 to Reduce Smoking
- 2.Participate in Health Approach 1 to Reduce Smoking
- 3.Participate in Smoking Cessation Counseling
- +1 more
DrugVarenicline
Routeoral
Primary goalChange in sleep duration
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
varenicline
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Change in sleep duration
Secondary: Change in blood pressure, Change in sleep quality
Body systems
Cardiology / Heart, Immune, Infectious